Tandem Diabetes Care, Inc. (TNDM)
USD 16.43
(-6.96%)
USD 16.43
(-6.96%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 367.69 Million USD | -10.97% |
| 2022 | 412.98 Million USD | 9.77% |
| 2021 | 376.21 Million USD | 44.41% |
| 2020 | 260.52 Million USD | 34.14% |
| 2019 | 194.21 Million USD | 116.22% |
| 2018 | 89.82 Million USD | 103.71% |
| 2017 | 44.09 Million USD | 86.9% |
| 2016 | 23.59 Million USD | -11.24% |
| 2015 | 26.58 Million USD | 74.32% |
| 2014 | 15.24 Million USD | 147.28% |
| 2013 | 6.16 Million USD | 557.36% |
| 2012 | -1.34 Million USD | 0.0% |
| 2011 | - USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 112.79 Million USD | 19.14% |
| 2024 Q1 | 94.67 Million USD | 1.48% |
| 2023 Q3 | 89.75 Million USD | -11.78% |
| 2023 Q1 | 82.9 Million USD | -28.23% |
| 2023 FY | 367.69 Million USD | -10.97% |
| 2023 Q4 | 93.29 Million USD | 3.95% |
| 2023 Q2 | 101.73 Million USD | 22.71% |
| 2022 Q2 | 101.94 Million USD | 11.91% |
| 2022 Q4 | 115.52 Million USD | 10.63% |
| 2022 FY | 412.98 Million USD | 9.77% |
| 2022 Q1 | 91.09 Million USD | -19.9% |
| 2022 Q3 | 104.42 Million USD | 2.43% |
| 2021 Q4 | 113.72 Million USD | 17.56% |
| 2021 Q3 | 96.74 Million USD | 4.64% |
| 2021 Q1 | 73.28 Million USD | -19.07% |
| 2021 Q2 | 92.45 Million USD | 26.15% |
| 2021 FY | 376.21 Million USD | 44.41% |
| 2020 Q4 | 90.55 Million USD | 38.65% |
| 2020 FY | 260.52 Million USD | 34.14% |
| 2020 Q3 | 65.31 Million USD | 20.08% |
| 2020 Q2 | 54.39 Million USD | 8.22% |
| 2020 Q1 | 50.26 Million USD | -16.61% |
| 2019 Q4 | 60.27 Million USD | 18.92% |
| 2019 FY | 194.21 Million USD | 116.22% |
| 2019 Q1 | 33.35 Million USD | -19.7% |
| 2019 Q2 | 49.9 Million USD | 49.62% |
| 2019 Q3 | 50.68 Million USD | 1.56% |
| 2018 Q3 | 21.79 Million USD | 44.47% |
| 2018 Q2 | 15.08 Million USD | 32.3% |
| 2018 Q1 | 11.4 Million USD | -34.71% |
| 2018 FY | 89.82 Million USD | 103.71% |
| 2018 Q4 | 41.53 Million USD | 90.56% |
| 2017 Q2 | 8 Million USD | 18.5% |
| 2017 Q1 | 6.75 Million USD | -32.91% |
| 2017 FY | 44.09 Million USD | 86.9% |
| 2017 Q4 | 17.46 Million USD | 47.13% |
| 2017 Q3 | 11.87 Million USD | 48.36% |
| 2016 Q1 | 6.92 Million USD | -48.52% |
| 2016 FY | 23.59 Million USD | -11.24% |
| 2016 Q2 | 8.17 Million USD | 18.01% |
| 2016 Q4 | 10.06 Million USD | 738.24% |
| 2016 Q3 | -1.57 Million USD | -119.29% |
| 2015 Q2 | 4.8 Million USD | 70.98% |
| 2015 FY | 26.58 Million USD | 74.32% |
| 2015 Q3 | 5.51 Million USD | 14.83% |
| 2015 Q1 | 2.8 Million USD | -57.04% |
| 2015 Q4 | 13.45 Million USD | 144.11% |
| 2014 Q2 | 3.44 Million USD | 297.97% |
| 2014 FY | 15.24 Million USD | 147.28% |
| 2014 Q4 | 6.53 Million USD | 48.66% |
| 2014 Q3 | 4.39 Million USD | 27.49% |
| 2014 Q1 | 866.65 Thousand USD | -27.0% |
| 2013 Q3 | 2.53 Million USD | 524.05% |
| 2013 Q2 | 405.87 Thousand USD | -80.11% |
| 2013 Q1 | 2.04 Million USD | 555.99% |
| 2013 FY | 6.16 Million USD | 557.36% |
| 2013 Q4 | 1.18 Million USD | -53.13% |
| 2012 Q4 | -447.47 Thousand USD | 50.32% |
| 2012 Q3 | -900.78 Thousand USD | 0.0% |
| 2012 FY | -1.34 Million USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 2.55 Million USD | -14319.216% |
| BrainsWay Ltd. | 23.09 Million USD | -1492.352% |
| Cerus Corporation | 86.4 Million USD | -325.567% |
| Envoy Medical, Inc. | -473 Thousand USD | 77835.729% |
| electroCore, Inc. | 13.22 Million USD | -2680.054% |
| Helius Medical Technologies, Inc. | 61 Thousand USD | -602670.492% |
| IceCure Medical Ltd | 1.3 Million USD | -28183.846% |
| Inogen, Inc. | 126.69 Million USD | -190.207% |
| OrthoPediatrics Corp. | 111.25 Million USD | -230.499% |
| Lucid Diagnostics Inc. | -6.05 Million USD | 6177.521% |
| Monogram Orthopaedics, Inc. | -47.33 Thousand USD | 776866.098% |
| MaxCyte, Inc. | 36.54 Million USD | -906.102% |
| NeuroOne Medical Technologies Corporation | 456.51 Thousand USD | -80442.455% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -432171.338% |
| Orthofix Medical Inc. | 486.27 Million USD | 24.386% |
| PAVmed Inc | -3.96 Million USD | 9366.381% |
| Rapid Micro Biosystems, Inc. | -5.48 Million USD | 6803.555% |
| RxSight, Inc. | 53.76 Million USD | -583.884% |
| Sight Sciences, Inc. | 69.17 Million USD | -431.536% |
| SI-BONE, Inc. | 109.42 Million USD | -236.035% |
| TELA Bio, Inc. | 40.11 Million USD | -816.658% |
| Treace Medical Concepts, Inc. | 151.93 Million USD | -142.002% |
| Vivos Therapeutics, Inc. | 8.27 Million USD | -4345.533% |
| Acutus Medical, Inc. | -3.13 Million USD | 11821.071% |
| Talis Biomedical Corporation | 371 Thousand USD | -99007.817% |
| Spectral AI, Inc. | 7.88 Million USD | -4566.117% |
| Nano-X Imaging Ltd. | -6.59 Million USD | 5677.822% |
| CVRx, Inc. | 33.03 Million USD | -1012.897% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 739.52 Thousand USD | -49619.685% |
| Bioventus Inc. | 328.19 Million USD | -12.035% |
| Venus Concept Inc. | 52.16 Million USD | -604.833% |
| TriSalus Life Sciences, Inc. | 15.9 Million USD | -2211.643% |
| LivaNova PLC | 771.25 Million USD | 52.325% |
| 908 Devices Inc. | 25.32 Million USD | -1352.057% |
| Alphatec Holdings, Inc. | 310.2 Million USD | -18.532% |
| Nemaura Medical Inc. | -1.47 Million USD | 25004.632% |
| NeuroPace, Inc. | 48.12 Million USD | -664.079% |
| LENSAR, Inc. | 21.1 Million USD | -1642.029% |
| Apyx Medical Corporation | 14.12 Million USD | -2503.668% |
| Cutera, Inc. | 41.49 Million USD | -786.128% |
| STRATA Skin Sciences, Inc. | 18.46 Million USD | -1891.712% |
| BioSig Technologies, Inc. | 18 Thousand USD | -2042622.222% |
| Anika Therapeutics, Inc. | 103.08 Million USD | -256.676% |
| ClearPoint Neuro, Inc. | 13.61 Million USD | -2600.823% |
| Integra LifeSciences Holdings Corporation | 888.39 Million USD | 58.612% |
| Axonics, Inc. | 274.55 Million USD | -33.923% |
| Outset Medical, Inc. | 29 Million USD | -1167.897% |
| IRIDEX Corporation | 21.8 Million USD | -1586.11% |
| PROCEPT BioRobotics Corporation | 71.04 Million USD | -417.516% |
| IRadimed Corporation | 50.15 Million USD | -633.06% |
| Tivic Health Systems, Inc. | 287 Thousand USD | -128014.983% |
| INVO Bioscience, Inc. | 1.08 Million USD | -33752.973% |
| Telesis Bio, Inc. | 16.95 Million USD | -2069.263% |
| Viemed Healthcare, Inc. | 112.78 Million USD | -226.015% |
| Varex Imaging Corporation | 256.9 Million USD | -43.126% |
| Quipt Home Medical Corp. | 163.84 Million USD | -124.413% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 90664.039% |
| Pulmonx Corporation | 50.75 Million USD | -624.484% |
| Dynatronics Corporation | 7.63 Million USD | -4715.862% |
| Modular Medical, Inc. | -768 Thousand USD | 47976.302% |
| ReShape Lifesciences Inc. | 5.54 Million USD | -6527.433% |
| Semler Scientific, Inc. | 61.2 Million USD | -500.801% |
| InMode Ltd. | 411.34 Million USD | 10.612% |
| Bruker Corporation | 1.51 Billion USD | 75.759% |
| Cytosorbents Corporation | 22.39 Million USD | -1542.058% |
| DexCom, Inc. | 2.28 Billion USD | 83.936% |
| Align Technology, Inc. | 2.71 Billion USD | 86.476% |
| Viveve Medical, Inc. | 620 Thousand USD | -59204.839% |
| ZimVie Inc. | 290.38 Million USD | -26.622% |
| Movano Inc. | -158 Thousand USD | 232815.19% |
| Cytek Biosciences, Inc. | 109.42 Million USD | -236.017% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -432171.338% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Profound Medical Corp. | 4.51 Million USD | -8045.509% |
| Insulet Corporation | 1.15 Billion USD | 68.3% |
| enVVeno Medical Corporation | -546 Thousand USD | 67442.491% |
| Surmodics, Inc. | 93.05 Million USD | -295.145% |
| iCAD, Inc. | 14.53 Million USD | -2429.513% |
| Nuwellis, Inc. | 4.98 Million USD | -7278.888% |
| Biotricity, Inc. | 8.35 Million USD | -4300.163% |
| iRhythm Technologies, Inc. | 331.8 Million USD | -10.815% |
| Aethlon Medical, Inc. | -359.05 Thousand USD | 102504.354% |
| InspireMD, Inc. | 1.8 Million USD | -20248.091% |
| PAVmed Inc. | -3.96 Million USD | 9366.381% |
| BIOLASE, Inc. | 16.72 Million USD | -2098.577% |
| Beyond Air, Inc. | -1.3 Million USD | 28232.364% |
| FONAR Corporation | 45.14 Million USD | -714.554% |
| AxoGen, Inc. | 127.87 Million USD | -187.541% |
| Vivani Medical, Inc. | -357 Thousand USD | 103094.398% |
| Tactile Systems Technology, Inc. | 195.13 Million USD | -88.43% |
| Inari Medical, Inc. | 434.56 Million USD | 15.389% |
| UFP Technologies, Inc. | 112.22 Million USD | -227.636% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 12.51 Thousand USD | -2936955.675% |
| Tenon Medical, Inc. | 1.24 Million USD | -29528.525% |
| Autonomix Medical, Inc. Common Stock | -81 Thousand USD | 454038.272% |
| Co-Diagnostics, Inc. | 2.62 Million USD | -13896.1% |
| AdaptHealth Corp. | 479.56 Million USD | 23.328% |
| Sintx Technologies, Inc. | 1.84 Million USD | -19850.624% |
| NanoVibronix, Inc. | 1.53 Million USD | -23822.576% |
| Quanterix Corporation | 70.64 Million USD | -420.468% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 90664.039% |
| Sensus Healthcare, Inc. | 14.06 Million USD | -2515.149% |
| Pacific Biosciences of California, Inc. | 52.78 Million USD | -596.646% |
| TransMedics Group, Inc. | 154.09 Million USD | -138.616% |
| ReWalk Robotics Ltd. | 4.45 Million USD | -8157.13% |
| NeuroMetrix, Inc. | 3.94 Million USD | -9214.708% |
| Hyperfine, Inc. | 4.75 Million USD | -7629.451% |
| Establishment Labs Holdings Inc. | 106.97 Million USD | -243.709% |
| Biomerica, Inc. | 611 Thousand USD | -60078.396% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 41.68 Million USD | -782.017% |
| Bluejay Diagnostics, Inc. | -780.95 Thousand USD | 47182.098% |
| Silk Road Medical, Inc | 127.08 Million USD | -189.324% |